Xome Appoints Chief Technology Officer

Xome Appoints Chief Technology Officer

Seasoned Technology Leader to Spearhead Digital Transformation and Innovation

DALLAS–(BUSINESS WIRE)–Xome® announced today it has appointed James Curl as Senior Vice President and Chief Technology Officer. Curl brings more than 15 years of experience leading technology and innovation teams at major organizations such as T-Mobile and Deloitte, where he oversaw large scale digital transformation initiatives.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221004005968/en/

James Curl, Xome Chief Technology Officer (Photo: Business Wire)

James Curl, Xome Chief Technology Officer (Photo: Business Wire)

Curl will lead the Xome enterprise-wide technology team and initiatives to create and source transformative technology solutions that will continue to build upon the company’s strong foundation.

“We are thrilled to have James join the Xome team to continue growing our technology platforms and better serve both our customers and team members,” said Mike Rawls, CEO, Xome. “We are confident his wealth of experience and proven track record of leading teams will strengthen our technology solutions and further our culture of innovation.”

Prior to joining Xome, Curl served as Vice President of Enterprise and Emerging Technology at T-Mobile, where he led cross functional teams of product managers and engineers to deliver market shaping technology products including T-Mobile’s consumer home internet. Curl also led the technology shared service functions at T-Mobile including enterprise architecture, portfolio management and solution delivery. Prior to his time at T-Mobile, Curl worked at Deloitte Consulting in the technology strategy and architecture service area, where he led major technology implementations for clients. Curl holds a bachelor’s degree in computer engineering from Texas A&M University.

“I am excited to join Xome’s tech-forward and digitally focused team, and I look forward to supporting the company’s best-in-class auction platform as we continue to propel Xome to the forefront of the industry,” said Curl.

About Xome

Xome Holdings LLC is a premier asset management company with a best-in-class auction platform providing mortgage servicers end-to-end asset marketing and disposition strategies, recapture solutions and real estate and data services. Based in the Dallas area, Xome is an indirect wholly-owned subsidiary of Mr. Cooper Group Inc. (NASDAQ: COOP). For more information, please visit www.xome.com.

Xome Media Contact

Christen Reyenga, VP Corporate Communications

[email protected]

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Other Construction & Property Residential Building & Real Estate Construction & Property

MEDIA:

Logo
Logo
Photo
Photo
James Curl, Xome Chief Technology Officer (Photo: Business Wire)

SEE to Hold Conference Call to Discuss Third Quarter 2022 Results

SEE to Hold Conference Call to Discuss Third Quarter 2022 Results

CHARLOTTE, N.C.–(BUSINESS WIRE)–
Sealed Air Corporation (NYSE: SEE) announced today that it will release its third quarter 2022 results at approximately 7:00 a.m. (ET) on Tuesday, November 1, 2022 and will host a conference call and webcast at 10:00 a.m. (ET).

Ted Doheny, President and CEO, and Chris Stephens, SVP and CFO, will conduct the investor conference call. The conference will be webcast live. Interested parties can view the events on Sealed Air’s Investors homepage at www.sealedair.com/investors.

About SEE

Sealed Air (NYSE: SEE) is in business to protect, solve critical packaging challenges, and make our world better than we find it. Our automated packaging solutions promote a safer, more resilient, and less wasteful global food supply chain, enable e-commerce, and protect goods transported worldwide.

Our globally recognized brands include CRYOVAC® brand food packaging, SEALED AIR® brand protective packaging, AUTOBAG® brand automated systems, BUBBLE WRAP® brand packaging, SEEAutomation™ solutions and prismiq™ brand smart packaging and digital printing.

SEE’s Operating Model, together with our industry-leading expertise in materials, engineering and technology, create value through more sustainable, automated, and digitally connected packaging solutions.

We are leading the packaging industry in creating a more environmentally, socially, and economically sustainable future and have pledged to design or advance 100% of our packaging materials to be recyclable or reusable by 2025, with a bolder goal to reach net-zero carbon emissions in our global operations by 2040. Our Global Impact Report highlights how we are shaping the future of the packaging industry. We are committed to a diverse workforce and caring, inclusive culture through our 2025 Diversity, Equity and Inclusion pledge.

SEE generated $5.5 billion in sales in 2021 and has approximately 16,500 employees who serve customers in 114 countries/territories. To learn more, visit sealedair.com.

Website Information

We routinely post important information for investors on our website, sealedair.com, in the Investors section. We use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investors section of our website, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

Investors

Brian Sullivan

[email protected]

704.503.8841

Media

Christina Griffin

[email protected]

704.430.5742

KEYWORDS: North Carolina United States North America

INDUSTRY KEYWORDS: Packaging Chemicals/Plastics Manufacturing

MEDIA:

Logo
Logo

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, Oct. 04, 2022 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema,” “Olema Oncology” or the “Company,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that the Company granted stock options to four new employees to purchase an aggregate of 58,300 shares of the Company’s common stock, effective as of October 3, 2022. These awards were approved by the Compensation Committee of Olema’s Board of Directors and granted under the Company’s 2022 Inducement Plan, with a grant date of October 3, 2022, as an inducement material to the new employee entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).

The stock options vest over four years, with 25 percent vesting on the first anniversary of the vesting commencement date for such employee and the remainder vesting in 36 equal monthly installments over the following three years, subject to the employee being continuously employed by Olema as of such vesting dates. The stock options have a 10-year term and an exercise price of $2.91 per share, equal to the last reported sale price of the Company’s common stock as reported by Nasdaq on October 3, 2022. The stock options are subject to the terms of the Olema Pharmaceuticals, Inc., 2022 Inducement Plan.

Olema is providing this information in accordance with Nasdaq Listing Rule 5635(c)(4).

About Olema Oncology

Olema Oncology is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers. Olema’s lead product candidate, OP-1250, is an orally available small molecule with combined activity as both a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). It is currently being evaluated as a single agent in an ongoing Phase 1/2 clinical trial, and in Phase 1b combination with palbociclib, in patients with recurrent, locally advanced or metastatic ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Olema is headquartered in San Francisco and has operations in Cambridge, Massachusetts.

Contact:
Shane Kovacs, COO and CFO
[email protected]



Amylyx Pharmaceuticals Announces Launch of Public Offering

Amylyx Pharmaceuticals Announces Launch of Public Offering

CAMBRIDGE, Mass.–(BUSINESS WIRE)–
Amylyx Pharmaceuticals, Inc. (“Amylyx”) today announced the launch of an underwritten public offering of 6,000,000 shares of common stock pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (“SEC”). All of the shares of common stock are being offered by Amylyx. Amylyx expects to grant the underwriters a 30-day option to purchase up to an additional 900,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or the actual size or terms of the offering.

Goldman Sachs & Co. LLC, BofA Securities, SVB Securities, and Evercore ISI are acting as joint book-running managers for the proposed offering. H.C. Wainwright & Co. is acting as lead manager for the proposed offering.

The proposed offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus relating to the proposed offering may be obtained from: Goldman Sachs & Co. LLC, at Prospectus Department, 200 West Street, New York, New York 10282, by telephone at 1-866-471-2526 or by e-mail at [email protected]; BofA Securities, Inc., Attention: Prospectus Department, 200 North College Street, 3rd floor, Charlotte NC 28255-0001 or by email at [email protected]; SVB Securities LLC, Attention: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, by telephone at 1-800-808-7525, ext. 6105, or by email at [email protected]; or Evercore Group L.L.C., Attention: Equity Capital Markets, 55 East 52nd Street, 35th Floor, New York, New York 10055, by telephone at 1-888-474-0200, or by email at [email protected].

A registration statement on Form S-1 relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy these securities be accepted, prior to the time the registration statement becomes effective.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Amylyx Pharmaceuticals

Amylyx Pharmaceuticals, Inc. is committed to supporting and creating more moments for the neurodegenerative community through the discovery and development of innovative new treatments. Amylyx is headquartered in Cambridge, Massachusetts and has operations in Canada and EMEA.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements”, including with respect to the proposed offering. No assurance can be given that the offering discussed above will be completed on the terms described, or at all. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Any forward-looking statements in this statement are based on management’s current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. Risks that contribute to the uncertain nature of the forward-looking statements include those risks and uncertainties set forth in Amylyx’s registration statement on Form S-1 filed with the United States Securities and Exchange Commission and the preliminary prospectus included therein. Copies of the registration statement can be accessed by visiting the Securities and Exchange Commission website at www.sec.gov. All forward-looking statements contained in this press release speak only as of the date on which they were made. Amylyx undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Media

Becky Gohsler

Finn Partners

(646) 307-6307

[email protected]

Investors

Lindsey Allen

Amylyx Pharmaceuticals, Inc.

(857) 320-6244

[email protected]

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Research FDA Neurology Clinical Trials Biotechnology Managed Care Health Pharmaceutical Science

MEDIA:

Logo
Logo

Essential Properties Realty Trust, Inc. to Report Third Quarter 2022 Results on October 27, 2022

Essential Properties Realty Trust, Inc. to Report Third Quarter 2022 Results on October 27, 2022

PRINCETON, N.J.–(BUSINESS WIRE)–
Essential Properties Realty Trust, Inc. (NYSE: EPRT; “Essential Properties” or the “Company”) announced today that the Company will release its operating results for the third quarter ended September 30, 2022, after the market close on Thursday, October 27, 2022. The Company will host its third quarter 2022 earnings conference call and audio webcast on Friday, October 28, 2022, at 11:00 a.m. Eastern Time to discuss its operating results.

A webcast of the conference call will be available on the Investor Relations section of the Company’s website at www.essentialproperties.com. To listen to the live broadcast, go to the site at least 15 minutes prior to the scheduled start time in order to register, download and install any necessary audio software.

Direct Link to Webcast:

https://viavid.webcasts.com/starthere.jsp?ei=1575106&tp_key=bf87b0432d

To Participate in the Telephone Conference Call:

Dial in at least five minutes prior to start time

Domestic: 877-407-9208

International: 201-493-6784

Conference Call Playback:

Domestic: 844-512-2921

International: 412-317-6671

Replay Pin: 13733465

About Essential Properties Realty Trust, Inc.

Essential Properties Realty Trust, Inc. is an internally managed REIT that acquires, owns and manages primarily single-tenant properties that are net leased on a long-term basis to companies operating service-oriented or experience-based businesses. As of June 30, 2022, the Company’s portfolio consisted of 1,561 freestanding net lease properties with a weighted average lease term of 13.8 years and a weighted average rent coverage ratio of 4.0x. In addition, as of June 30, 2022, the Company’s portfolio was 99.9% leased to 322 tenants operating 469 different concepts in 16 industries across 46 states.

Investor/Media:

Essential Properties Realty Trust, Inc.

Daniel Donlan

Senior Vice President, Capital Markets

609-436-0619

[email protected]

KEYWORDS: New York New Jersey United States North America

INDUSTRY KEYWORDS: Professional Services Residential Building & Real Estate Commercial Building & Real Estate Finance Construction & Property REIT

MEDIA:

Logo
Logo

Albany International Schedules Earnings Release Date

Albany International Schedules Earnings Release Date

ROCHESTER, N.H.–(BUSINESS WIRE)–
Albany International Corp. (NYSE:AIN) will release 2022 third-quarter financial results Monday, October 24, 2022 after the market close.

The Company will host a webcast to discuss results at 9:00 a.m. Eastern Time on Tuesday, October 25. Interested parties are encouraged to listen to the webcast via the Company’s Investor Relations website atwww.albint.com.

Those without internet access may dial into the conference at 1-844-291-6362. Please provide your name, company, and access code 3726015 to the operator.

A replay of the webcast will be available on the website at approximately noon Eastern Time October 25.

About Albany International Corp.

Albany International is a leading developer and manufacturer of engineered components, using advanced materials processing and automation capabilities, with two core businesses. Machine Clothing is the world’s leading producer of custom-designed, consumable fabrics and process belts essential for the manufacture of all grades of paper products. Albany Engineered Composites is a growing designer and manufacturer of advanced materials-based engineered components for demanding aerospace applications, supporting both commercial and military platforms. Albany International is headquartered in Rochester, New Hampshire, operates 23 facilities in 11 countries, employs approximately 4,100 people worldwide, and is listed on the New York Stock Exchange (Symbol AIN). Additional information about the Company and its products and services can be found at www.albint.com.

John Hobbs

603-330-5897

[email protected]

KEYWORDS: New Hampshire United States North America

INDUSTRY KEYWORDS: Aerospace Manufacturing Other Manufacturing Air Transport

MEDIA:

Logo
Logo

MFA Financial, Inc. Plans Live Audio Webcast of Third Quarter 2022 Earnings Conference Call

PR Newswire


NEW YORK
, Oct. 4, 2022 /PRNewswire/ — MFA Financial, Inc. (NYSE: MFA) plans to host a live audio webcast of its investor conference call on Thursday, November 3, 2022, at 10:00 a.m. (Eastern Time) to discuss its third quarter 2022 financial results, which are scheduled to be announced earlier that day.

The live audio webcast will be accessible to the general public over the internet at http://www.mfafinancial.com by clicking on the “Webcasts & Presentations” link on MFA’s home page.  To listen to the conference call over the internet, please go to the MFA website at least 15 minutes before the call to register and to download and install any needed audio software.  Earnings presentation materials will be posted on the MFA website prior to the conference call and an audio replay will be available on the website following the call.

MFA Financial, Inc. is a leading specialty finance company that invests in and finances residential mortgage assets.  MFA invests, on a leveraged basis, in residential whole loans, residential mortgage-backed securities and other real estate assets.  Through its subsidiaries, MFA also originates and services business purpose loans for real estate investors.  MFA is an internally-managed, publicly-traded real estate investment trust.

Category: Earnings


CONTACT:

[email protected]

212-207-6488

www.mfafinancial.com

Cision View original content:https://www.prnewswire.com/news-releases/mfa-financial-inc-plans-live-audio-webcast-of-third-quarter-2022-earnings-conference-call-301640877.html

SOURCE MFA Financial, Inc.

Clipper Realty Inc. Announces Change of Auditor

Clipper Realty Inc. Announces Change of Auditor

NEW YORK–(BUSINESS WIRE)–
Clipper Realty Inc. (NYSE: CLPR) (the “Company”) announced today that its Audit Committee approved the appointment of PKF O’Connor Davies, LLP (“PKF”) as the Company’s independent registered public accounting firm for the Company’s year ending December 31, 2022, replacing BDO USA, LLP (“BDO”).

The decision to change the Company’s independent registered public accounting firm was based primarily on the Audit Committee’s efforts to reduce the Company’s costs for audit services.

The Company has not had any disagreements with BDO through the date of disengagement, nor any disagreements related to any prior years’ audits.

About Clipper Realty Inc.

Clipper Realty Inc. (NYSE: CLPR) is a self-administered and self-managed real estate company that acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. For more information on the Company, please visit www.clipperrealty.com.

Lawrence Kreider

Chief Financial Officer

(718) 438-2804 x2231

[email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Accounting Professional Services Residential Building & Real Estate Commercial Building & Real Estate Construction & Property

MEDIA:

Logo
Logo

TreeHouse Foods Announces Webcast of Third Quarter 2022 Earnings Conference Call

PR Newswire


OAK BROOK, Ill.
, Oct. 4, 2022 /PRNewswire/ — TreeHouse Foods, Inc. (NYSE: THS) will host an audio webcast of its third quarter earnings results conference call on Monday, November 7, 2022 at 8:30 a.m. ET. Steve Oakland, Chief Executive Officer and President, and Patrick O’Donnell, Interim Chief Financial Officer and Chief Accounting Officer, will discuss the results for the third quarter and the outlook for the balance of the year. An earnings release will be issued before the market opens on the same date, and the accompanying slides will be posted to the “Investors” section of the website at approximately 8:15 a.m. ET. The webcast will be accessible by visiting http://www.treehousefoods.com under “Investors”, “Events & Presentations”.

A webcast replay will be available under the “Investors”, “Events & Presentations”, “Archived Events & Presentations” section of the Company’s website.

ABOUT TREEHOUSE FOODS

TreeHouse Foods, Inc. is a leading manufacturer and distributor of private label foods and beverages in North America. We operate in 18 product categories and have 26 manufacturing facilities across North America. Our purpose is to make high quality food and beverages affordable to all. Our vision is to be the undisputed solutions leader for our custom brands. Our mission is to create value as our customers’ preferred manufacturing and distribution partner, providing thought leadership, superior innovation, and a relentless focus on execution. Our long-term strategic objective is to build a company that is well positioned to deliver long-term sustainable growth and create value for our shareholders.

Additional information, including TreeHouse’s most recent statements on Forms 10-Q and 10-K, may be found at TreeHouse’s website, http://www.treehousefoods.com.

Cision View original content:https://www.prnewswire.com/news-releases/treehouse-foods-announces-webcast-of-third-quarter-2022-earnings-conference-call-301640713.html

SOURCE TreeHouse Foods, Inc.

Healthpeak Properties to Report Third Quarter Financial Results and Host Conference Call/Webcast

PR Newswire


DENVER
, Oct. 4, 2022 /PRNewswire/ — Healthpeak Properties, Inc. (NYSE: PEAK) is scheduled to report its third quarter financial results after the close of trading on the New York Stock Exchange on Tuesday, November 1, 2022. Healthpeak will host a conference call and webcast on Wednesday, November 2, 2022, at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time) in order to review its financial performance and operating results for the third quarter ended September 30, 2022.

The dial-in number for the conference call is (888) 317-6003 (U.S.) or (412) 317-6061 (international). The conference ID number is 4482164. You may also access the conference call via webcast at https://ir.healthpeak.com/webcasts. An archive of the webcast will be available on Healthpeak’s website through November 2, 2023, and a telephonic replay can be accessed through November 8, 2022, by calling (877) 344-7529 (U.S.) or (412) 317-0088 (international) and entering conference ID number 4571885.

ABOUT HEALTHPEAK PROPERTIES

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and CCRC. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth. For more information regarding Healthpeak, visit www.healthpeak.com.

CONTACT

Andrew Johns, CFA
Senior Vice President – Investor Relations
720-428-5400

 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/healthpeak-properties-to-report-third-quarter-financial-results-and-host-conference-callwebcast-301640828.html

SOURCE Healthpeak Properties, Inc.